A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
about
A36-dependent actin filament nucleation promotes release of vaccinia virusA survey of host range genes in poxvirus genomesVaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesinPoxviruses and the evolution of host range and virulenceA protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.The formin FHOD1 and the small GTPase Rac1 promote vaccinia virus actin-based motility.Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.Complement evasion by human pathogens.Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L proteinMurine gammaherpesvirus 68 encodes a functional regulator of complement activationRole of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particlesHuman antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope proteinThe vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses.The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesiclesThere is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions.In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.Characterization of the vaccinia virus A35R protein and its role in virulence.The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus.Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.Identification of second-site mutations that enhance release and spread of vaccinia virus.Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Smallpox vaccines: targets of protective immunity.Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteinsIdentification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus.Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organsParainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.
P2860
Q27335617-C383EFCD-1F78-41AA-B226-0741ACF13B8FQ28389388-0B73A466-B3D6-430A-8875-3FDD73DA7EEEQ28576187-89521E2B-0F64-4E3A-B220-A59DCDB94805Q28658130-5D686B77-C777-4767-BFFA-359359E58821Q30445071-A2E7E986-5FA7-4660-94AE-3F8E7C917C61Q30524111-13A374E0-29FD-46B8-BD38-B53F77E560C2Q30547698-B4F314CA-8465-46D9-9C02-A809378A7134Q30809790-87B4D206-1877-4060-A8FF-C3446413752BQ31905797-B6E21312-7ED4-4F2E-BC53-C20DFAE9722EQ33623972-972B726E-38A7-4EE6-B1F1-C63BB6D33EBAQ33640531-4FFABF02-36B2-497E-8487-B7C6E9F941F0Q33650182-D0EB2FED-E17F-45CA-90A1-CDDC835EF3CEQ33707339-1B8C59E7-BB04-4CF2-AB01-36AA944169B2Q33743444-B6E3F341-2FBB-4699-A56D-2DB57DEB249CQ33780553-464E22A1-8CB6-4D14-B16A-47B9AAA5DA99Q33780579-1EA9E1E1-95BD-46C1-8284-5F14ABDEB547Q33782803-954DB8B3-422E-4B4B-8FB2-B42DB559C838Q33802619-9D80181B-D6CA-408D-A447-F4EAE3241840Q33803352-A8BCF761-075F-4012-9333-9C2486AAB6BBQ33811821-0B305FCB-EA6D-484C-8E92-1DF3D8A41C6BQ33812636-046E0C29-9C5A-4488-B419-87288935A873Q33834854-1BA14858-68E5-4E28-8051-E92129A42756Q33852860-107E9606-7C02-4E50-A5C6-46B772586198Q33857450-01D1C2D6-25B1-4B0A-B2D0-822151C257E0Q34017475-50E40628-6CE6-4018-BB41-84BF609F9F9FQ34233032-F8F74E66-5AB1-418B-B8F5-5EFFDA99F09CQ34312168-357BA332-9D2E-4CFA-A020-6C225E3AF5A1Q34343103-17E775C3-589F-47E3-B771-72995F040C45Q34356729-18B38C56-6CBB-45D0-A11E-445499B97484Q34420319-042955AB-DA02-497B-9764-9CC31F5602F4Q34478724-CC3B76A2-EA84-4A54-8B05-EBBFF8404547Q34780607-1E44FA50-DF76-4AFE-8A80-9DD533A9FC9BQ34781856-4961F72A-C4D9-45F0-9A44-1FC7ED58E4E1Q35172311-7C30777A-9154-4BA0-AF42-02EACACF6DF1Q35182349-350D32F8-51EB-4A18-AAF4-CCF69822EE1BQ35192889-D7EA60F1-22D5-44FC-9EA3-008F39770CC5Q35226200-AF4339AF-2111-4444-ABD5-3F95D8735928Q35234767-AE48D3BF-365E-4CB2-8206-6A8405874553Q35557123-1B171B12-D4F2-4EE3-B730-BA94B91DDAE6Q35760869-9902409F-BFF3-4772-A9A3-D759A1B84650
P2860
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
A constitutively expressed vac ...... extracellular virus envelope.
@en
A constitutively expressed vac ...... extracellular virus envelope.
@nl
type
label
A constitutively expressed vac ...... extracellular virus envelope.
@en
A constitutively expressed vac ...... extracellular virus envelope.
@nl
prefLabel
A constitutively expressed vac ...... extracellular virus envelope.
@en
A constitutively expressed vac ...... extracellular virus envelope.
@nl
P2093
P1433
P1476
A constitutively expressed vac ...... extracellular virus envelope.
@en
P2093
P304
P356
10.1016/0042-6822(92)90535-W
P407
P577
1992-06-01T00:00:00Z